These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2796850)

  • 1. History and current status of neuroblastoma screening in Japan.
    Takeda T
    Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH; Oberrauch W; Schanz F; Treuner J
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG; Tuchman M; Lemieux B
    Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroblastoma: the case for screening infants in North America.
    Woods WG; Tuchman M
    Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
    Auray-Blais C; Giguère R; Lemieux B
    Med Pediatr Oncol; 1989; 17(5):364-7. PubMed ID: 2796851
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection].
    Satokata I; Asami T; Otsuka T; Sakai K
    Rinsho Byori; 1986 Jul; 34(7):817-22. PubMed ID: 3761638
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
    Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G; Falcone R; De Bernardi B; Canini S
    Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
    [No Abstract]   [Full Text] [Related]  

  • 13. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
    Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
    Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
    CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma screening: the Canadian experience.
    Lemieux B; Auray-Blais C; Giguère R; Scriver CR
    Med Pediatr Oncol; 1989; 17(5):379-81. PubMed ID: 2796854
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory techniques and neuroblastoma screening.
    Sawada T
    Lancet; 1988 Nov; 2(8620):1134-5. PubMed ID: 2903341
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for neuroblastoma (NB) in North America: the Quebec Project.
    Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
    Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
    [No Abstract]   [Full Text] [Related]  

  • 20. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
    Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
    Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.